Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The first decade of advanced cell therapy clinical trials using perinatal cells (2005-2015).

Couto PS, Bersenev A, Verter F.

Regen Med. 2017 Dec;12(8):953-968. doi: 10.2217/rme-2017-0066. Epub 2017 Nov 15. Review.

2.

CAR-T cell manufacturing: time to put it in gear.

Bersenev A.

Transfusion. 2017 May;57(5):1104-1106. doi: 10.1111/trf.14110. No abstract available.

PMID:
28425600
3.

[Varicocele in second adulthood and elderly men].

Tarasko AD, Bersenev AE, Salamanov VI.

Urologiia. 2014 Mar-Apr;(2):48-51. Russian.

PMID:
24956673
4.

Convergence of gene and cell therapy.

Bersenev A, Levine BL.

Regen Med. 2012 Nov;7(6 Suppl):50-6. doi: 10.2217/rme.12.71. Review.

PMID:
23210811
5.

Lnk deficiency partially mitigates hematopoietic stem cell aging.

Bersenev A, Rozenova K, Balcerek J, Jiang J, Wu C, Tong W.

Aging Cell. 2012 Dec;11(6):949-59. doi: 10.1111/j.1474-9726.2012.00862.x. Epub 2012 Aug 27.

6.

14-3-3 regulates the LNK/JAK2 pathway in mouse hematopoietic stem and progenitor cells.

Jiang J, Balcerek J, Rozenova K, Cheng Y, Bersenev A, Wu C, Song Y, Tong W.

J Clin Invest. 2012 Jun;122(6):2079-91. doi: 10.1172/JCI59719. Epub 2012 May 1.

7.

MicroRNA expression in maturing murine megakaryocytes.

Opalinska JB, Bersenev A, Zhang Z, Schmaier AA, Choi J, Yao Y, D'Souza J, Tong W, Weiss MJ.

Blood. 2010 Dec 2;116(23):e128-38. doi: 10.1182/blood-2010-06-292920. Epub 2010 Aug 18.

8.

Lnk constrains myeloproliferative diseases in mice.

Bersenev A, Wu C, Balcerek J, Jing J, Kundu M, Blobel GA, Chikwava KR, Tong W.

J Clin Invest. 2010 Jun;120(6):2058-69. doi: 10.1172/JCI42032. Epub 2010 May 10.

9.

FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment.

Gregory GD, Miccio A, Bersenev A, Wang Y, Hong W, Zhang Z, Poncz M, Tong W, Blobel GA.

Blood. 2010 Mar 18;115(11):2156-66. doi: 10.1182/blood-2009-10-251280. Epub 2010 Jan 11.

10.

Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice.

Huang J, Zhang Y, Bersenev A, O'Brien WT, Tong W, Emerson SG, Klein PS.

J Clin Invest. 2009 Dec;119(12):3519-29. doi: 10.1172/JCI40572.

11.

Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2.

Bersenev A, Wu C, Balcerek J, Tong W.

J Clin Invest. 2008 Aug;118(8):2832-44. doi: 10.1172/JCI35808.

12.

[Influence of cell therapy and alimentary correction on the condition of microcirculatory system in experimental dyslipidemia].

Kobozeva LP, Michunskaia AB, Kulikova OS, Bersenev AV, Klimenko ED, Onishchenko NA, Pozdniakov OM.

Patol Fiziol Eksp Ter. 2005 Oct-Dec;(4):28-9. Russian.

PMID:
16408665
13.

[Experimental substantiation of the efficiency of using the stem and progenitory cells of the bone marrow for regulating the recovery processes in organs in acute and chronic affections].

Shumakov VI, Onishchenko NA, Krasheninnikov ME, Rasulov MF, Potapov IV, Bersenev AV, Zań≠denov VA, Bashkina LV, Zorin VL, Pozdniakov OM, Kobozeva LP, Klimenko ED.

Vestn Ross Akad Med Nauk. 2004;(9):44-7. Russian. No abstract available.

PMID:
15526686
14.

Dyslipidogenic microangiopathy in guinea pigs at early stages of atherogenesis.

Bersenev AV, Klimenko ED, Kobozeva LP, Michunskaya AB, Onishchenko NA, Pozdnyakov OM.

Bull Exp Biol Med. 2003 Aug;136(2):117-9.

PMID:
14631486
15.

Differentiation of bone marrow stromal stem cells into cardiomyocyte-like cells in different mammalian species.

Shumakov VI, Onishchenko NA, Krasheninnikov ME, Zaidenov VA, Potapov IV, Bashkina LV, Bersenev AV.

Bull Exp Biol Med. 2003 Apr;135(4):393-6.

PMID:
12910318

Supplemental Content

Loading ...
Support Center